Subscribe
shutterstock_1635580639_sundry_photography
Sundry Photography / Shutterstock.com
8 July 2021GenericsRory O'Neill

Taiwanese biotech built on ‘foundation of lies’, says DoJ

US prosecutors have charged the founders of Taiwanese biosimilar manufacturer JHL Biotech with stealing  Genentech trade secrets.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Genentech to face revived Hemlibra claims
28 August 2020   Genentech and Chugai Pharmaceutical will have to face claims that its haemophilia drug Hemlibra (emicizumab-kxwh) infringed a patent owned by Takeda subsidiary Baxalta.
Biotechnology
English court sides with Eli Lilly in Genentech jurisdictional clash
8 December 2017   The English High Court has sided with Eli Lilly in holding that its UK-related claims in a patent case can be heard together with its European-based arguments in the UK.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
Genentech to face revived Hemlibra claims
28 August 2020   Genentech and Chugai Pharmaceutical will have to face claims that its haemophilia drug Hemlibra (emicizumab-kxwh) infringed a patent owned by Takeda subsidiary Baxalta.
Biotechnology
English court sides with Eli Lilly in Genentech jurisdictional clash
8 December 2017   The English High Court has sided with Eli Lilly in holding that its UK-related claims in a patent case can be heard together with its European-based arguments in the UK.

More on this story

Big Pharma
Genentech to face revived Hemlibra claims
28 August 2020   Genentech and Chugai Pharmaceutical will have to face claims that its haemophilia drug Hemlibra (emicizumab-kxwh) infringed a patent owned by Takeda subsidiary Baxalta.
Biotechnology
English court sides with Eli Lilly in Genentech jurisdictional clash
8 December 2017   The English High Court has sided with Eli Lilly in holding that its UK-related claims in a patent case can be heard together with its European-based arguments in the UK.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?